Project 1: The relationship between Neuropsychological Testing and MRI, PET, and
Project 1: The relationship between Neuropsychological Testing and MRI, PET, and
批准号:
9312828
负责人:
SARAH BANKS
金额:
$39.12万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAffectAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAnimal ModelAnteriorBiological AssayBiological MarkersBloodBrainBrain regionCenters of Research ExcellenceClinicalClinical ResearchCognitionCognition DisordersCognitiveComplementDataDevelopmentDiagnosisDiseaseDisease MarkerDistressEncephalitisExecutive DysfunctionFunctional Magnetic Resonance ImagingFundingGeneticGenetic MarkersGenetic screening methodGrantHumanImageImpaired cognitionImpairmentIndividualInflammationInvestigationLearningLinkMagnetic Resonance ImagingMeasuresMedialMemoryMemory impairmentMentorsMethodsMonitorNerve DegenerationNeurobiologyNeurodegenerative DisordersNeuropsychological TestsNeuropsychologyOutcome MeasureParkinson DiseasePathologic ProcessesPatientsPerformancePharmaceutical PreparationsPopulationPositron-Emission TomographyProcessPublic HealthResearchRestRodentSchemeSeverity of illnessStatistical Data InterpretationSurrogate MarkersSymptomsTREM2 geneTechniquesTemporal LobeTest ResultTestingTransgenic MiceTranslatingTranslational ResearchTranslationsVisuospatialWorkcohortdata managementexperiencegenetic risk factorhuman diseaseinnovationloved onesmild cognitive impairmentmorris water mazemouse modelneuroimagingneuroimaging markernovelnovel markerpredict clinical outcomeskillsstatisticstranslational neurosciencevirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Neurodegenerative diseases including Alzheimer's (AD) and Parkinson's disease (PD) are distressing
conditions for those affected and their loved ones, and represent a growing burden on public health funds.
These diseases are becoming increasingly prevalent as the population ages. Neuropsychological decline is the
hallmark of early AD, and is common in PD. Such symptoms are identified and tracked with
neuropsychological tests, which are also important in testing new medications. Recent breakthroughs have led
to further understanding of the underlying neurobiology of AD and PD, but how these new findings relate to
neuropsychological testing is largely unknown. This project will inform our interpretation of
neuropsychological testing in relation to novel neuroimaging and genetic biomarkers of AD and PD. In AD,
we will we will study the brain at rest using functional magnetic resonance imaging (fMRI), and learn how the
connectivity of the brain's networks relate to neuropsychological testing. We will also use a novel adaptation
of a task traditionally used in rodent studies, the Morris Water Maze, and understand this in the context of
connectivity at rest during fMRI. Other aspects of the project will involve both AD and PD: we will use a novel
method to assess inflammation in the brain, and understand how regional inflammation relates to different
types of cognitive impairment. We will also discover how genetic biomarkers of inflammation and AD risk
relate to neuropsychology. By gaining better understanding of the correlations of neuropsychology and these
novel biomarkers we will be able to inform interpretation of both sets of techniques. Neuropsychology is
currently central to the monitoring of novel medications being tested in both diseases, and understanding the
neurobiological processes underlying our findings will be central in contributing to the development of new
medications. The studies outlined in this project proposal will generate preliminary data to answer further
questions about the neuropsychology of these diseases. In combination with a detailed mentoring scheme, the
studies proposed here and the experience gained if funded will result in the project leader being a competitive
candidate for independent research funding.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biological and lifestyle factors contributing to Tau in women at risk for Alzheimer's disease.
-
批准号:10591159
-
项目类别:
-
资助金额:$102.59万
-
财政年份:2023
-
负责人:SARAH BANKS
-
依托单位:
Understanding Biological and Lifestyle Contributions to Alzheimer's Disease Pathology and Clinical Profiles in Black Women: Defining Prevention Targets in High Risk Groups
-
批准号:10591000
-
项目类别:
-
资助金额:$81.59万
-
财政年份:2022
-
负责人:SARAH BANKS
-
依托单位:
Sex-specific cognitive expression and risk in preclinical Alzheimer's disease
-
批准号:10336899
-
项目类别:
-
资助金额:$2.05万
-
财政年份:2019
-
负责人:SARAH BANKS
-
依托单位:
Sex-specific cognitive expression and risk in preclinical Alzheimer's disease
-
批准号:10017125
-
项目类别:
-
资助金额:$71.11万
-
财政年份:2019
-
负责人:SARAH BANKS
-
依托单位:
Sex-specific cognitive expression and risk in preclinical Alzheimer's disease
-
批准号:10646223
-
项目类别:
-
资助金额:$75.78万
-
财政年份:2019
-
负责人:SARAH BANKS
-
依托单位:
Sex-specific cognitive expression and risk in preclinical Alzheimer's disease
-
批准号:10200671
-
项目类别:
-
资助金额:$75.76万
-
财政年份:2019
-
负责人:SARAH BANKS
-
依托单位:
Sex-specific cognitive expression and risk in preclinical Alzheimer's disease
-
批准号:10416197
-
项目类别:
-
资助金额:$12.33万
-
财政年份:2019
-
负责人:SARAH BANKS
-
依托单位:
Sex-specific cognitive expression and risk in preclinical Alzheimer's disease
-
批准号:10417213
-
项目类别:
-
资助金额:$75.78万
-
财政年份:2019
-
负责人:SARAH BANKS
-
依托单位:
Sex-specific cognitive expression and risk in preclinical Alzheimer's disease
-
批准号:10634349
-
项目类别:
-
资助金额:$10.28万
-
财政年份:2019
-
负责人:SARAH BANKS
-
依托单位:
海外基金